IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Sortica, Vinicius A ^a   Cunha, Maristela G ^b   Ohnishi, Maria Deise O ^c   Souza, Jose M ^c   Ribeiro Dos Santos, Ândrea Kc ^b   Santos, Ney Pc ^b   Callegari Jacques, Sídia M ^a   Santos, Sidney Eb ^b   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Brazilian amazon; IL12RB1; IL1B; IL4R; Immune system polymorphisms; Malaria; Plasmodium vivax; TNF

Indexed keywords

GAMMA INTERFERON RECEPTOR 1; IFNG PROTEIN; IL12RB1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN; PURINERGIC P2X7 RECEPTOR; SP110 PROTEIN; TNFRSF1A PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VDR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE DELETION; GENOTYPE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; BRAZIL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOST-PARASITE INTERACTIONS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; MALARIA, VIVAX; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-12; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84870500357     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-409     Document Type: Article

References (50)

1. WHO, World malaria report 2011 http://www.who.int/malaria/world-malaria- report-2011/9789241564403-eng.pdf
2. Vivax malaria: neglected and not benign. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, AmJTrop Med Hyg 2007 77 79 87
3. Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the "symptomatic" vs "asymptomatic" dichotomy. da Silva-Nunes M, Ferreira MU, Mem Inst Oswaldo Cruz 2007 102 341 347 10.1590/S0074-02762007005000051 17568940
4. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR, PLoS Negl Trop Dis 2008 2 300 10.1371/journal.pntd.0000300 18820747
5. Plasmodium vivax malaria: status in the republic of Korea following reemergence. Park JW, Jun G, Yeom JS, Korean J Parasitol 2009 47 Suppl 39 50 10.3347/kjp.2009.47.S.S39
6. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Lacerda MV, Mourão MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa FE, Filho FS, Brasil P, Ventura AM, Tada MS, Couto VS, Silva AR, Silva RS, Alecrim MG, Malar J 2012 11 12 10.1186/1475-2875-11-12 22230294
7. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA, Lancet Infect Dis 2009 9 555 566 10.1016/S1473-3099(09)70177-X 19695492
8. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Good MF, Xu H, Wykes M, Engwerda CR, Annu Rev Immunol 2005 23 69 99 10.1146/annurev.immunol.23.021704. 115638 15771566
9. Regulating immunity to malaria. Riley EM, Wahl S, Perkins DJ, Schofield L, Parasite Immunol 2006 28 35 49 10.1111/j.1365-3024.2006.00775.x 16438675
10. Immunity to malaria: more questions than answers. Langhorne J, Ndungu FM, Sponaas AM, Marsh K, Nat Immunol 2008 9 725 732 18563083
11. Genetic polymorphisms linked to susceptibility to malaria. Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK, Malar J 2011 10 271 10.1186/1475-2875-10-271 21929748
12. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients. Sohail M, Kaul A, Bali P, Raziuddin M, Singh MP, Singh OP, Dash AP, Adak T, Mol Immunol 2008 45 1682 1692 10.1016/j.molimm.2007.10.002 17996942
13. Increased interleukin-10 and interferon-γ levels in plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Medina TS, Costa SP, Oliveira MD, Ventura AM, Souza JM, Gomes TF, Vallinoto AC, Póvoa MM, Silva JS, Cunha MG, Malar J 2011 10 264 10.1186/1475-2875-10-264 21917128
14. Manual de diagnóstico laboratorial da malária 2005 http://portal.saude.gov.br/portal/arquivos/pdf/manual-diagnostico-malaria.pdf
15. Sambrook J, Fritsch EF, Maniatis T, Molecular cloning. A laboratory manual Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press 2 1989
16. Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Santos NP, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AK, Pereira R, Gusmão L, Amorim A, Guerreiro JF, Zago MA, Matte C, Hutz MH, Santos SE, Hum Mutat 2010 31 184 190 10.1002/humu.21159 19953531
17. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Stephens M, Donnelly P, Am J Hum Genet 2003 73 1162 1169 10.1086/379378 14574645
18. Inference of population structure using multilocus genotype data. Pritchard JK, Stephens M, Donnelly P, Genetics 2000 155 945 959 10835412
19. Association mapping in structured populations. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P, Am J Hum Genet 2000 67 170 181 10.1086/302959 10827107
20. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR, Nucleic Acids Res 2011 39 913 D919 10.1093/nar/gkq1128 21062830
21. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, KehdyFde S, Kohlrausch F, Magno LA, Montenegro RC, Moraes MO, de Moraes ME, de Moraes MR, Ojopi EB, Perini JA, Racciopi C, Ribeiro-Dos-Santos AK, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G, PLoS One 2011 6 17063 10.1371/journal.pone.0017063 21359226
22. Biologic basis for interleukin-1 in disease. Dinarello CA, Blood 1996 87 2095 2147 8630372
23. IL-18: A TH1-inducing, pro inflammatory cytokine and new member of the IL-1 family. Dinarello CA, J Allergy Clin Immunol 1999 103 11 24 10.1016/S0091-6749(99)70518-X 9893178
24. Immunological and inflammatory functions of the interleukin-1 family. Dinarello CA, Annu Rev Immunol 2009 27 519 550 10.1146/annurev.immunol.021908. 132612 19302047
25. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, Immunity 2006 24 179 189 10.1016/j.immuni.2006. 01.001 16473830
26. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong C, Immunity 2009 30 576 587 10.1016/j.immuni.2009.02.007 19362022
27. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff TH, Science 1998 280 1435 1438 10.1126/science.280.5368. 1435 9603733
28. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Trinchieri G, Blood 1994 84 4008 4027 7994020
29. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Grau GE, Piguet PF, Vassalli P, Lambert PH, Immunol Rev 1989 112 49 70 10.1111/j.1600-065X.1989.tb00552.x 2575074
30. Polymorphisms in interleukin-1beta and interleukin-1 receptor antagonist genes and malaria in Ghanaian children. Gyan B, Goka B, Cvetkovic JT, Perlmann H, Lefvert AK, Akanmori B, Troye-Blomberg M, Scand J Immunol 2002 56 619 622 10.1046/j.1365-3083.2002.01161.x 12472674
31. Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Walley AJ, Aucan C, Kwiatkowski D, Hill AV, Eur J Hum Genet 2004 12 132 138 10.1038/sj.ejhg.5201084 14673470
32. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. Ouma C, Davenport GC, Awandare GA, Keller CC, Were T, Otieno MF, Vulule JM, Martinson J, Ong'echa JM, Ferrell RE, Perkins DJ, J Infect Dis 2008 198 1219 1226 10.1086/592055 18781863
33. A functional polymorphism in the IL1B gene promoter, IL1B -31C > T, is not associated with cerebral malaria in Thailand. Ohashi J, Naka I, Doi A, Patarapotikul J, Hananantachai H, Tangpukdee N, Looareesuwan S, Tokunaga K, Malar J 2005 4 38 10.1186/1475-2875-4-38 16098232
34. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya. Zhang L, Prather D, VandenEng J, Crawford S, Kariuki S, TerKuile F, Terlouw D, Nahlen B, Lal AA, Slutsker L, Udhayakumar V, Shi YP, Malar J 2010 9 87 10.1186/1475-2875-9-87 20350312
35. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, Nature 1994 371 508 510 10.1038/371508a0 7935762
36. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, J Infect Dis 1999 179 287 290 10.1086/314533 9841857
37. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Sinha S, Mishra SK, Sharma S, Patibandla PK, Mallick PK, Sharma SK, Mohanty S, Pati SS, Mishra SK, Ramteke BK, Bhatt R, Joshi H, Dash AP, Ahuja RC, Awasthi S, Venkatesh V, Habib S, Indian Genome Variation Consortium, Malar J 2008 7 13 10.1186/1475-2875-7-13 18194515
38. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A, Richardson A, Small K, Teo YY, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP, J Infect Dis 2009 199 569 575 10.1086/596320 19281305
39. Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity. Kuesap J, Hirayama K, Kikuchi M, Ruangweerayut R, Na-Bangchang K, Malar J 2010 9 260 10.1186/1475-2875-9-260 20846452
40. CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation. Hünig T, Lühder F, Elflein K, Gogishvili T, Fröhlich M, Guler R, Cutler A, Brombacher F, Med Microbiol Immunol 2010 199 239 246 10.1007/s00430-010-0156-z 20390297
41. Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with plasmodium berghei (ANKA) than do naive wild-type mice. Saeftel M, Krueger A, Arriens S, Heussler V, Racz P, Fleischer B, Brombacher F, Hoerauf A, Infect Immun 2004 72 322 331 10.1128/IAI.72.1.322- 331.2004 14688111
42. IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. Morrot A, Hafalla JC, Cockburn IA, Carvalho LH, Zavala F, J Exp Med 2005 202 551 560 10.1084/jem.20042463 16087712
43. Malaria. Garcia LS, Clin Lab Med 2010 30 93 129 10.1016/j.cll.2009.10.001 20513543
44. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, Ho M, J Infect Dis 1999 180 1288 1297 10.1086/315016 10479160
45. Serum levels of the pro inflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, Infect Immun 2004 72 5630 5637 10.1128/IAI.72.10.5630-5637.2004 15385460
46. Human malarial disease: a consequence of inflammatory cytokine release. Clark IA, Budd AC, Alleva LM, Cowden WB, Malar J 2006 5 85 10.1186/1475-2875-5- 85 17029647
47. Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of central India. Prakash D, Fesel C, Jain R, Cazenave PA, Mishra GC, Pied S, J Infect Dis 2006 194 198 207 10.1086/504720 16779726
48. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Karunaweera ND, Carter R, Grau GE, Kwiatkowski D, Del Giudice G, Mendis KN, Clin Exp Immunol 1992 88 499 505 1351432
49. The paroxysm of plasmodium vivax malaria. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R, Trends Parasitol 2003 19 188 193 10.1016/S1471-4922(03)00036-9 12689650
50. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. Zeyrek FY, Kurcer MA, Zeyrek D, Simsek Z, Parasite Immunol 2006 28 201 207 10.1111/j.1365-3024.2006.00822.x 16629705